Nice Insight adds new feature for Q4
In Q4, Nice Insight is offering a downloadable PDF option for the Marcom Tracker.
Nice Insight releases its Q3 Report
On September 15th, Nice Insight released its Q3 CRO / CMO report.
Nice Insight is featured on iDeaTurf Consulting
Nice Insight’s press release announcing the launch of its Q3 CRO / CMO Report was featured on iDeaTurf Consulting.
Nice Insight is featured in PharmaLive
Nice Insight’s press release announcing the launch of its Q3 CRO / CMO Report was featured in PharmaLive.
Nice Insight launches Q3 trends page
Nice Insight releases its latest Q3 trends, which were garnered from data
from its Pharmaceutical and Biotechnology Outsourcing survey results.
Don't miss Nice Insight's webinar
Nice Insight is hosting a webinar at 10:00AM EDT tomorrow – discussing how its survey data can improve collaborations between CROs / CMOs and Big Pharma.
Nice Insight builds list of media partners
Nice Insight continues to add new media partners, including Pharmaceutical Manufacturing and Pharmaceutical Processing.
Nice Insight survives Hurricane Irene
Nice Insight braves Hurricane Irene and returns to business as usual.
Nice Insight tabulates Q3 results
The Nice Insight team is busy tabulating results from its Q3 survey. The Q3
CRO/CMO report launches on September 15th.
3000+ respondents for Nice Insight’s Q3 survey
Nice Insight’s Q3 survey generated results from over 3000 respondents from the pharmaceutical and biotechnology industries, in the most successful turnout to date.
Nice Insight closes Q3 survey
Nice Insight closes its Q3 survey and is in the process of analyzing the data.
Nice Insight announces a lead generation tool
Nice Insight announces a Q3 upgrade that will initially offer CROs and CMOs
500+ qualified leads comprising pharma and biotech companies seeking
outsourcing partners. This will be expanded beyond 1,500 leads within a year
and will be available within Nice Insight subscribed services.
Webinar announced for Nice Insight
Nice Insight will host a webinar at 10:00AM EDT on September 13, 2011 –
discussing how its survey data can improve collaborations between CROs /
CMOs and Big Pharma.
Nice Insight launches publicly-traded company tracker
Nice Insight has added a feature that tracks a correlation in stock
performance and CA / CP performance in quarterly industry surveys.
Nice Insight launches shopping cart in Q3
Nice Insight will launch a shopping cart feature for Q3 that allows clients to customize reports to meet their needs.
Nice Insight in Pharmaceutical Technology magazine
Pharmaceutical Technology magazine featured Nice Insight’s data in its August issue.
5 new CROs added to Q3 report
Nice Insight added 5 new CROs to its Q3 report.
Q3 survey respondents quickly adding up
Nice Insight delivered its Q3 survey earlier this week and the number of respondents is already climbing steadily into the hundreds.
Nice Insight featured in Life Science Leader
Nice Insight is featured in Life Science Leader's August issue in an article examining regulatory support services and compliance.
New capabilities module in development
Nice Insight begins the development of a new company capabilities module, which will provide more detailed data on specific product and service offerings.
Nice Insight in the midst of Q3 research
The Nice Insight team is in the process of researching the new companies to be added to the Q3 CRO / CMO report.
Nice Insight implements new pricing structure
Nice Insight offers an updated pricing structure that allows clients to purchase annual subscriptions to our quarterly reports.
Nice Insight launches first issue of newsletter
The first issue of Industry Insights -- a newsletter featuring proprietary data from Nice Insight's CRO / CMO report -- makes a successful debut.
Nice Insight well received at DIA and BIO
Nice Insight receives overwhelming support from the CRO /CMO community while attending DIA and the Bio International Convention.